They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...
Weight loss jab tirzepatide – commonly sold under the brand name Mounjaro – is set to become available via the NHS for ...
The decision to limit Mounjaro injections to 220,000 people is ‘short-sighted and absurd’, says the former prime minister’s ...
The rollout of the weight-loss drug to 3.4 million eligible patients could take up to 12 years, according to NICE.
Despite an estimated 3.4 million people in England meeting the eligibility criteria for Mounjaro, fewer than 10% will ...
Alix Harvey, a 35-year-old marine biologist from Plymouth, welcomed the move to increase access to the weight-loss drug. She ...
With obesity rates skyrocketing in the UK, the a 28-year-old social media specialist expressed support for the wider ...
“Mounjaro is the brand name for tirzepatide, a weekly injectable weight-loss medication which has recently been approved for ...
Millions of NHS patients could wait 12 years for weight-loss drug Mounjaro, which rivals Ozempic and Wegovy. Although the ...
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people eligible, but will be made available in stages to limit the financial impact.